biospecimen_aliquot__bcr_aliquot_barcode	tcga-e2-a1b1-01a-21d-a12q-09
biospecimen_aliquot__bcr_aliquot_uuid	a6e77a14-e5e5-452e-a46f-5629ee8228e3
biospecimen_aliquot__bcr_patient_uuid	8a0ef221-8070-43fc-9d98-def90abe4871
biospecimen_aliquot__bcr_sample_barcode	tcga-e2-a1b1-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0108431851
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-02-22
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	5
biospecimen_aliquot__plate_id	a12q
biospecimen_aliquot__plate_row	e
biospecimen_aliquot__quantity	3.20
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__a260_a280_ratio	1.93
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-e2-a1b1-01a-21d
biospecimen_analyte__bcr_analyte_uuid	46a72219-594f-4dfa-9f38-04626ee9e99b
biospecimen_analyte__bcr_patient_uuid	8a0ef221-8070-43fc-9d98-def90abe4871
biospecimen_analyte__bcr_sample_barcode	tcga-e2-a1b1-01a
biospecimen_analyte__concentration	0.17
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-e2-a1b1
biospecimen_diagnostic_slides__bcr_patient_uuid	8a0ef221-8070-43fc-9d98-def90abe4871
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-e2-a1b1-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	7c8df153-b09b-44c7-87b8-14591e319354
biospecimen_normal_control__bcr_patient_barcode	tcga-e2-a1b1
biospecimen_normal_control__bcr_patient_uuid	8a0ef221-8070-43fc-9d98-def90abe4871
biospecimen_normal_control__ncedna_dna_conc	0.482
biospecimen_normal_control__ncedna_dna_qm	picogreen
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	42
biospecimen_portion__bcr_patient_uuid	8a0ef221-8070-43fc-9d98-def90abe4871
biospecimen_portion__bcr_portion_barcode	tcga-e2-a1b1-01a-21
biospecimen_portion__bcr_portion_uuid	a953af96-dfb6-4703-8caf-fc3900fb619e
biospecimen_portion__bcr_sample_barcode	tcga-e2-a1b1-01a
biospecimen_portion__date_of_creation	2011-01-06
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	21
biospecimen_portion__portion_sequence	2
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-e2-a1b1-01a-21d
biospecimen_protocol__bcr_patient_uuid	8a0ef221-8070-43fc-9d98-def90abe4871
biospecimen_protocol__bcr_sample_barcode	tcga-e2-a1b1-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	8a0ef221-8070-43fc-9d98-def90abe4871
biospecimen_sample__bcr_sample_barcode	tcga-e2-a1b1-01a
biospecimen_sample__bcr_sample_uuid	1cb37b69-c0a9-4b5c-baf5-4107d0e029ad
biospecimen_sample__days_to_collection	1268
biospecimen_sample__initial_weight	300
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-e2-a1b1.431ae1cb-9605-45e3-b6c3-5253b24655d6.pdf
biospecimen_sample__pathology_report_uuid	431ae1cb-9605-45e3-b6c3-5253b24655d6
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	8a0ef221-8070-43fc-9d98-def90abe4871
biospecimen_shipment_portion__bcr_sample_barcode	tcga-e2-a1b1-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	c476545a-0d56-4d49-9180-bb707d02a1c9
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a13e
biospecimen_shipment_portion__portion_number	11
biospecimen_shipment_portion__portion_sequence	1
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-e2-a1b1-01a-11-a13e-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	22
biospecimen_shipment_portion__shipment_portion_month_of_shipment	3
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	8a0ef221-8070-43fc-9d98-def90abe4871
biospecimen_slide__bcr_sample_barcode	tcga-e2-a1b1-01a
biospecimen_slide__bcr_slide_barcode	tcga-e2-a1b1-01a-02-tsb
biospecimen_slide__bcr_slide_uuid	8d1372de-544d-4c67-9e8f-09bcd33db672
biospecimen_slide__image_file_name	tcga-e2-a1b1-01a-02-tsb.8d1372de-544d-4c67-9e8f-09bcd33db672.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	5
biospecimen_slide__percent_stromal_cells	35
biospecimen_slide__percent_tumor_cells	60
biospecimen_slide__percent_tumor_nuclei	70
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-e2-a1b1
biospecimen_tumor_sample__bcr_patient_uuid	8a0ef221-8070-43fc-9d98-def90abe4871
clinical_drug__bcr_drug_barcode	tcga-e2-a1b1-d19421
clinical_drug__bcr_drug_uuid	347d45d4-7a50-4c57-9caf-b7be348bde4f
clinical_drug__bcr_patient_barcode	tcga-e2-a1b1
clinical_drug__bcr_patient_uuid	8a0ef221-8070-43fc-9d98-def90abe4871
clinical_drug__form_completion_date	2011-12-9
clinical_drug__pharmaceutical_therapy_drug_name	triptorelin
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_dose_units	mg
clinical_drug__pharmaceutical_tx_ongoing_indicator	yes
clinical_drug__pharmaceutical_tx_started_days_to	71
clinical_drug__pharmaceutical_tx_total_dose_units	mg
clinical_drug__prescribed_dose	3.75
clinical_drug__regimen_number	03
clinical_drug__route_of_administration	im
clinical_drug__therapy_regimen	adjuvant
clinical_follow_up__bcr_followup_barcode	tcga-e2-a1b1-f70009
clinical_follow_up__bcr_followup_uuid	87d15560-4ae5-45ad-b931-54de2e14c301
clinical_follow_up__bcr_patient_barcode	tcga-e2-a1b1
clinical_follow_up__bcr_patient_uuid	8a0ef221-8070-43fc-9d98-def90abe4871
clinical_follow_up__followup_lost_to	no
clinical_follow_up__form_completion_date	2015-2-9
clinical_follow_up__last_contact_days_to	2653
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__pharmaceutical_tx_adjuvant	yes
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	45
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n1
clinical_patient__ajcc_pathologic_tumor_stage	stage iib
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left upper outer quadrant
clinical_patient__axillary_staging_method	sentinel node biopsy alone
clinical_patient__bcr_patient_barcode	tcga-e2-a1b1
clinical_patient__bcr_patient_uuid	8a0ef221-8070-43fc-9d98-def90abe4871
clinical_patient__birth_days_to	-16603
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_positivity_method	allred score 3+2 = 5
clinical_patient__er_positivity_scale_other	allred score = 5
clinical_patient__er_status_by_ihc	positive
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-4-25
clinical_patient__gender	female
clinical_patient__her2_cent17_ratio	15.12
clinical_patient__her2_fish_status	positive
clinical_patient__her2_ihc_percent_positive	70-79%
clinical_patient__her2_ihc_score	2+
clinical_patient__her2_status_by_ihc	equivocal
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2007
clinical_patient__last_contact_days_to	1361
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	6
clinical_patient__lymph_nodes_examined_he_count	1
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	tumor resection
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a1b1
clinical_patient__pr_positivity_define_method	allred score 2+2 = 4
clinical_patient__pr_positivity_scale_other	allred score = 4
clinical_patient__pr_status_by_ihc	positive
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	lumpectomy
clinical_patient__tissue_source_site	e2
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-e2-a1b1
clinical_radiation__bcr_patient_uuid	8a0ef221-8070-43fc-9d98-def90abe4871
clinical_radiation__bcr_radiation_barcode	tcga-e2-a1b1-r19440
clinical_radiation__bcr_radiation_uuid	06e5c1f9-947c-4ba4-8f46-ae56691487b8
clinical_radiation__course_number	01
clinical_radiation__form_completion_date	2011-12-9
clinical_radiation__radiation_adjuvant_fractions_total	31
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	314
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	302
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__radiation_total_dose	6000
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A1B1-01A-21D-A12Q-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A1B1-01A-21D-A12Q-09.bed.meta
manually_curated__id	tcga-e2-a1b1-01a-21d-a12q-09
manually_curated__md5sum	5c3113ce985ee43c10125dcd395f3836
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	a6e77a14-e5e5-452e-a46f-5629ee8228e3
manually_curated__tumor_tag	brca
